Enhancement of solubility in Escherichia coli and purification of an aminotransferase from Sphingopyxis sp. MTA144 for deamination of hydrolyzed fumonisin B1

Microbial Cell Factories

Volumn 9, Issue , 2010, Pages

  Hartinger, Doris ^a   Heinl, Stefan ^b   Schwartz, Heidi E ^c   Grabherr, Reingard ^b   Schatzmayr, Gerd ^a   Haltrich, Dietmar ^b   Moll, Wulf Dieter ^a  

^a BIOMIN RESEARCH CENTER   (Austria)

^b UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^c Institute for Agrobiotechnology Tulln   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BETAINE; CHAPERONIN; FUMONISIN B1; IMIDAZOLE; ISOPROPYL THIOGALACTOSIDE; MALTOSE BINDING PROTEIN; PYRIDOXAL 5 PHOSPHATE; SORBITOL; FUMONISIN; HYBRID PROTEIN;

ARTICLE; CELL INCLUSION; COLD ACCLIMATIZATION; CONTROLLED STUDY; DEAMINATION; DETOXIFICATION; ELUTION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INDUCTION; ENZYME PURIFICATION; ENZYME SYNTHESIS; ESCHERICHIA COLI; HYDROLYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN SYNTHESIS; SOLUBILITY; SPHINGOBACTERIACEAE; SPHINGOPYXIS; STRAIN DIFFERENCE; TEMPERATURE; BIOSYNTHESIS; CHEMISTRY; COLD; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; SPHINGOMONADACEAE;

ESCHERICHIA COLI; FUNGI; GIBBERELLA MONILIFORMIS; SPHINGOPYXIS;

COLD TEMPERATURE; DEAMINATION; ESCHERICHIA COLI; FUMONISINS; HYDROLYSIS; INCLUSION BODIES; RECOMBINANT FUSION PROTEINS; SOLUBILITY; SPHINGOMONADACEAE; TRANSAMINASES;

EID: 77955594628     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-9-62     Document Type: Article

References (69)

1. Heinl S, Hartinger D, Thamhesl M, Kunz-Vekiru E, Krska R, Schatzmayr G, Moll WD, Grabherr R. Degradation of fumonisin B1 by the consecutive action of two bacterial enzymes. J Biotechnol 2010, 145:120-129. 10.1016/j.jbiotec.2009.11.004, 19922747.
2. Marasas WF. Fumonisins: history, world-wide occurrence and impact. Adv Exp Med Biol 1996, 392:1-17.
3. Marasas WF. Discovery and occurrence of the fumonisins: a historical perspective. Environ Health Perspect 2001, 109:239-243. 10.2307/3435014, 1240671, 11359691.
4. Binder EM, Tan LM, Chin LJ, Handl J, Richard J. Worldwide occurrence of mycotoxins in commodities, feeds and feed ingredients. Anim Feed Sci Technol 2007, 137:265-282.
5. Gelderblom WC, Jaskiewicz K, Marasas WF, Thiel PG, Horak RM, Vleggaar R, Kriek NP. Fumonisins-novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme. Appl Environ Microbiol 1988, 54:1806-1811. 202749, 2901247.
6. Bezuidenhout SC, Gelderblom WCA, Gorst-Allman CP, Horak RM, Marasas WFO, Spiteller G, Vleggaar R. Structure elucidation of the fumonisins, mycotoxins from Fusarium moniliforme. J Chem Soc Chem Commun 1988, 743-745.
7. Marasas WF, Jaskiewicz K, Venter FS, Van Schalkwyk DJ. Fusarium moniliforme contamination of maize in oesophageal cancer areas in Transkei. S Afr Med J 1988, 74:110-114.
8. Harrison LR, Colvin BM, Greene JT, Newman LE, Cole JR. Pulmonary edema and hydrothorax in swine produced by fumonisin B1, a toxic metabolite of Fusarium moniliforme. J Vet Diagn Invest 1990, 2:217-221.
9. Kellerman TS, Marasas WF, Thiel PG, Gelderblom WC, Cawood M, Coetzer JA. Leukoencephalomalacia in two horses induced by oral dosing of fumonisin B1. Onderstepoort J Vet Res 1990, 57:269-275.
10. Gelderblom WC, Kriek NP, Marasas WF, Thiel PG. Toxicity and carcinogenicity of the Fusarium moniliforme metabolite, fumonisin B1, in rats. Carcinogenesis 1991, 12:1247-1251. 10.1093/carcin/12.7.1247, 1649015.
11. Rheeder JP, Marasas WFO, Thiel PG, Sydenham EW, Shephard GS, Van Schalkwyk DJ. Fusarium moniliforme and fumonisins in corn in relation to human esophageal cancer in Transkei. Phytopathology 1992, 82:353-357.
12. Ross PF, Ledet AE, Owens DL, Rice LG, Nelson HA, Osweiler GD, Wilson TM. Experimental equine leukoencephalomalacia, toxic hepatosis, and encephalopathy caused by corn naturally contaminated with fumonisins. J Vet Diagn Invest 1993, 5:69-74.
13. Chu FS, Li GY. Simultaneous occurrence of fumonisin B1 and other mycotoxins in moldy corn collected from the People's Republic of China in regions with high incidences of esophageal cancer. Appl Environ Microbiol 1994, 60:847-852. 201401, 8161178.
14. Hendricks K. Fumonisins and neural tube defects in South Texas. Epidemiology 1999, 10:198-200. 10.1097/00001648-199903000-00022, 10069261.
15. Haschek WM, Gumprecht LA, Smith G, Tumbleson ME, Constable PD. Fumonisin toxicosis in swine: an overview of porcine pulmonary edema and current perspectives. Environ Health Perspect 2001, 109(Suppl 2):251-257. 10.2307/3435016, 1240673, 11359693.
16. Voss KA, Riley RT, Norred WP, Bacon CW, Meredith FI, Howard PC, Plattner RD, Collins TF, Hansen DK, Porter JK. An overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliforme. Environ Health Perspect 2001, 109(Suppl 2):259-266. 10.2307/3435017, 1240674, 11359694.
17. Marasas WF, Riley RT, Hendricks KA, Stevens VL, Sadler TW, Gelineau-van WJ, Missmer SA, Cabrera J, Torres O, Gelderblom WC, Allegood J, Martinez C, Maddox J, Miller JD, Starr L, Sullards MC, Roman AV, Voss KA, Wang E, Merrill AH. Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J Nutr 2004, 134:711-716.
18. Norred WP, Voss KA, Bacon CW, Riley RT. Effectiveness of ammonia treatment in detoxification of fumonisin-contaminated corn. Food Chem Toxicol 1991, 29:815-819. 10.1016/0278-6915(91)90108-J, 1765326.
19. Sydenham EW, Van der Westhuizen L, Stockenstrom S, Shephard GS, Thiel PG. Fumonisin-contaminated maize: physical treatment for the partial decontamination of bulk shipments. Food Addit Contam 1994, 11:25-32.
20. Jackson LS, Hlywka JJ, Senthil KR, Bullerman LB. Effect of thermal processing on the stability of fumonisins. Adv Exp Med Biol 1996, 392:345-353.
21. Castelo MM, Sumner SS, Bullerman LB. Stability of fumonisins in thermally processed corn products. J Food Prot 1998, 61:1030-1033.
22. De Girolamo A, Solfrizzo M, Visconti A. Effect of processing on fumonisin concentration in corn flakes. J Food Prot 2001, 64:701-705.
23. Solfrizzo M, Carratu MR, Avantaggiato G, Galvano F, Pietri A, Visconti A. Ineffectiveness of activated carbon in reducing the alteration of sphingolipid metabolism in rats exposed to fumonisin-contaminated diets. Food Chem Toxicol 2001, 39:507-511. 10.1016/S0278-6915(00)00160-5, 11313118.
24. Avantaggiato G, Solfrizzo M, Visconti A. Recent advances on the use of adsorbent materials for detoxification of Fusarium mycotoxins. Food Addit Contam 2005, 22:379-388. 10.1080/02652030500058312, 16019808.
25. Voss KA, Smith GW, Haschek WM. Fumonisins: Toxicokinetics, mechanism of action and toxicity. Anim Feed Sci Technol 2007, 137:299-325.
26. Blackwell BA, Gilliam JT, Savard ME, David Miller J, Duvick JP. Oxidative deamination of hydrolyzed fumonisin B1 (AP1) by cultures of Exophiala spinifera. Natural Toxins 1999, 7:31-38. 10.1002/(SICI)1522-7189(199902)7:1<31::AID-NT36>3.0.CO;2-W, 10441035.
27. Duvick J, Maddox J, Gilliam J. Compositions and methods for fumonisin detoxification. 2003, US Patent 6538177 Pioneer Hi-Bred. Int. (USA).
28. Merrill AH, Wang E, Gilchrist DG, Riley RT. Fumonisins and other inhibitors of de novo sphingolipid biosynthesis. Adv Lipid Res 1993, 26:215-234.
29. Schmelz EM, Dombrink-Kurtzman MA, Roberts PC, Kozutsumi Y, Kawasaki T, Merrill AH. Induction of apoptosis by fumonisin B1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases. Toxicol Appl Pharmacol 1998, 148:252-260. 10.1006/taap.1997.8356, 9473533.
30. Humpf HU, Schmelz EM, Meredith FI, Vesper H, Vales TR, Wang E, Menaldino DS, Liotta DC, Merrill AH. Acylation of naturally occurring and synthetic 1-deoxysphinganines by ceramide synthase. Formation of N-palmitoyl-aminopentol produces a toxic metabolite of hydrolyzed fumonisin, AP1, and a new category of ceramide synthase inhibitor. J Biol Chem 1998, 273:19060-19064. 10.1074/jbc.273.30.19060, 9668088.
31. Seiferlein M, Humpf HU, Voss KA, Sullards MC, Allegood JC, Wang E, Merrill AH. Hydrolyzed fumonisins HFB1 and HFB2 are acylated in vitro and in vivo by ceramide synthase to form cytotoxic N-acyl-metabolites. Mol Nutr Food Res 2007, 51:1120-1130. 10.1002/mnfr.200700118, 17729221.
32. Sorensen HP, Mortensen KK. Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli. Microb Cell Fact 2005, 4:1. 10.1186/1475-2859-4-1, 544838, 15629064.
33. Waugh DS. Making the most of affinity tags. Trends Biotechnol 2005, 23:316-320. 10.1016/j.tibtech.2005.03.012, 15922084.
34. Esposito D, Chatterjee DK. Enhancement of soluble protein expression through the use of fusion tags. Curr Opin Biotechnol 2006, 17:353-358. 10.1016/j.copbio.2006.06.003, 16781139.
35. Schein CH, Noteborn MHM. Formation of Soluble Recombinant Proteins in Escherichia coli is Favored by Lower Growth Temperature. Bio/Technology 1988, 6:291-294.
36. Kolaj O, Spada S, Robin S, Wall JG. Use of folding modulators to improve heterologous protein production in Escherichia coli. Microb Cell Fact 2009, 8:9. 10.1186/1475-2859-8-9, 2642769, 19173718.
37. Weickert MJ, Doherty DH, Best EA, Olins PO. Optimization of heterologous protein production in Escherichia coli. Curr Opin Biotechnol 1996, 7:494-499. 10.1016/S0958-1669(96)80051-6, 8939627.
38. Mergulhao FJ, Summers DK, Monteiro GA. Recombinant protein secretion in Escherichia coli. Biotechnol Adv 2005, 23:177-202. 10.1016/j.biotechadv.2004.11.003, 15763404.
39. Georgiou G, Segatori L. Preparative expression of secreted proteins in bacteria: status report and future prospects. Curr Opin Biotechnol 2005, 16:538-545. 10.1016/j.copbio.2005.07.008, 16095898.
40. Bessette PH, Aslund F, Beckwith J, Georgiou G. Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm. Proc Natl Acad Sci USA 1999, 96:13703-13708. 10.1073/pnas.96.24.13703, 24128, 10570136.
41. Rosano GL, Ceccarelli EA. Rare codon content affects the solubility of recombinant proteins in a codon bias-adjusted Escherichia coli strain. Microb Cell Fact 2009, 8:41. 10.1186/1475-2859-8-41, 2723077, 19630980.
42. Schultz T, Martinez L, de Marco A. The evaluation of the factors that cause aggregation during recombinant expression in E. coli is simplified by the employment of an aggregation-sensitive reporter. Microb Cell Fact 2006, 5:28. 10.1186/1475-2859-5-28, 1564408, 16948849.
43. Blackwell JR, Horgan R. A novel strategy for production of a highly expressed recombinant protein in an active form. FEBS Lett 1991, 295:10-12. 10.1016/0014-5793(91)81372-F, 1765138.
44. Hammarstrom M, Hellgren N, van Den BS, Berglund H, Hard T. Rapid screening for improved solubility of small human proteins produced as fusion proteins in Escherichia coli. Protein Sci 2002, 11:313-321. 10.1110/ps.22102, 2373440, 11790841.
45. Kapust RB, Waugh DS. Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci 1999, 8:1668-1674. 10.1110/ps.8.8.1668, 2144417, 10452611.
46. Shih YP, Kung WM, Chen JC, Yeh CH, Wang AH, Wang TF. High-throughput screening of soluble recombinant proteins. Protein Sci 2002, 11:1714-1719. 10.1110/ps.0205202, 2373646, 12070324.
47. Cho HJ, Lee Y, Chang RS, Hahm MS, Kim MK, Kim YB, Oh YK. Maltose binding protein facilitates high-level expression and functional purification of the chemokines RANTES and SDF-1alpha from Escherichia coli. Protein Expr Purif 2008, 60:37-45. 10.1016/j.pep.2008.03.018, 18455434.
48. Ferrer M, Chernikova TN, Yakimov MM, Golyshin PN, Timmis KN. Chaperonins govern growth of Escherichia coli at low temperatures. Nat Biotechnol 2003, 21:1266-1267. 10.1038/nbt1103-1266, 14595348.
49. Joseph RE, Andreotti AH. Bacterial expression and purification of interleukin-2 tyrosine kinase: single step separation of the chaperonin impurity. Protein Expr Purif 2008, 60:194-197. 10.1016/j.pep.2008.04.001, 2581883, 18495488.
50. Thain A, Gaston K, Jenkins O, Clarke AR. A method for the separation of GST fusion proteins from co-purifying GroEL. Trends Genet 1996, 12:209-210. 10.1016/S0168-9525(96)90022-0, 8928224.
51. Rohman M, Harrison-Lavoie KJ. Separation of copurifying GroEL from glutathione-S-transferase fusion proteins. Protein Expr Purif 2000, 20:45-47. 10.1006/prep.2000.1271, 11035949.
52. Karlovsky P. Biological detoxification of fungal toxins and its use in plant breeding, feed and food production. Nat Toxins 1999, 7:1-23. 10.1002/(SICI)1522-7189(199902)7:1<1::AID-NT37>3.0.CO;2-9, 10441033.
53. Fuchs E, Binder EM, Heidler D, Krska R. Structural characterization of metabolites after the microbial degradation of type A trichothecenes by the bacterial strain BBSH 797. Food Additives and Contaminants 2002, 19:379-386. 10.1080/02652030110091154, 11962696.
54. Molnar O, Schatzmayr G, Fuchs E, Prillinger H. Trichosporon mycotoxinivorans sp. nov., a new yeast species useful in biological detoxification of various mycotoxins. Syst Appl Microbiol 2004, 27:661-671. 10.1078/0723202042369947, 15612623.
55. Benedetti R, Nazzi F, Locci R, Firrao G. Degradation of fumonisin B1 by a bacterial strain isolated from soil. Biodegradation 2006, 17:31-38. 10.1007/s10532-005-2797-y, 16453169.
56. Lei XG, Porres JM. Phytase enzymology, applications, and biotechnology. Biotechnol Lett 2003, 25:1787-1794. 10.1023/A:1026224101580, 14677699.
57. Li RY, Cheng CY. Investigation of inclusion body formation in recombinant Escherichia coli with a bioimaging system. J Biosci Bioeng 2009, 107:512-515. 10.1016/j.jbiosc.2009.01.025, 19393549.
58. Ceroni A, Passerini A, Vullo A, Frasconi P. DISULFIND: a disulfide bonding state and cysteine connectivity prediction server. Nucleic Acids Res 2006, 34:W177-W181. 10.1093/nar/gkl266, 1538823, 16844986.
59. Schlicke M, Brakmann S. Expression and purification of histidine-tagged bacteriophage T7 DNA polymerase. Protein Expr Purif 2005, 39:247-253. 10.1016/j.pep.2004.10.022, 15642476.
60. Picaud S, Olsson ME, Brodelius PE. Improved conditions for production of recombinant plant sesquiterpene synthases in Escherichia coli. Protein Expr Purif 2007, 51:71-79. 10.1016/j.pep.2006.06.025, 16908191.
61. Nomine Y, Ristriani T, Laurent C, Lefevre JF, Weiss E, Trave G. Formation of soluble inclusion bodies by hpv e6 oncoprotein fused to maltose-binding protein. Protein Expr Purif 2001, 23:22-32. 10.1006/prep.2001.1451, 11570842.
62. Zanier K, Nomine Y, Charbonnier S, Ruhlmann C, Schultz P, Schweizer J, Trave G. Formation of well-defined soluble aggregates upon fusion to MBP is a generic property of E6 proteins from various human papillomavirus species. Protein Expr Purif 2007, 51:59-70. 10.1016/j.pep.2006.07.029, 17055740.
63. Schein CH. Production of soluble recombinant proteins in bacteria. Bio/Technology 1989, 7:1141-1149.
64. Ferrer M, Chernikova TN, Timmis KN, Golyshin PN. Expression of a temperature-sensitive esterase in a novel chaperone-based Escherichia coli strain. Appl Environ Microbiol 2004, 70:4499-4504. 10.1128/AEM.70.8.4499-4504.2004, 492381, 15294778.
65. Sambrook J, Russell DW. Molecular cloning: A laboratory manual 2001, New York, USA: Cold Spring Harbor Laboratory Press.
66. Studier FW, Rosenberg AH, Dunn JJ, Dubendorff JW. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 1990, 185:60-89. full_text, 2199796.
67. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685. 10.1038/227680a0, 5432063.
68. Burnette WN. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981, 112:195-203. 10.1016/0003-2697(81)90281-5, 6266278.
69. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254. 10.1016/0003-2697(76)90527-3, 942051.